This inventor holds 3 USPTO granted patents. Top assignees: Dynavax Technologies Corporation, Medigen Vaccine Biologics Corporation, Valneva Austria Gmbh. Active years: 2023-2026.
Company Filing History:
3 out of 66 
1 out of 1 
1 out of 46 
Years Active: 2023-2026
Title: The Innovative Contributions of John Campbell in Vaccine Development
Introduction
John Campbell, an inventive mind based in Emeryville, CA, has made significant strides in the field of vaccine development. As an inventor with a focus on addressing global health challenges, his contributions are noteworthy, particularly in the fight against SARS-CoV-2.
Latest Patents
John Campbell holds one patent, which focuses on the development of CpG-adjuvanted SARS-CoV-2 vaccines. This patent describes compositions and methods for producing and administering these vaccines to individuals in need, highlighting innovative approaches to enhancing immune responses against the virus.
Career Highlights
Throughout his career, John has worked with prominent companies in the biotechnology sector. He has contributed his expertise at Valneva Austria GmbH and Dynavax Technologies Corporation, both of which are known for their advancements in vaccine technology and therapeutic solutions.
Collaborations
In his professional journey, John has collaborated with skilled individuals, including his coworkers Andreas Meinke and Michael Möhlen. Their combined efforts contribute to the innovation and efficiency in vaccine research and development.
Conclusion
John Campbell’s work exemplifies the crucial role of inventors in enhancing public health through innovative solutions like vaccines. His dedication to research and collaboration continues to drive advancements in the fight against infectious diseases.